Clinical Trial Update: Tamoxifen Treatment in Patients With Motor Neuron Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on tamoxifen treatment in patients with motor neuron disease (ALS), encompassing Phase 1 and Phase 2 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Taipei Medical University Shuang Ho Hospital | Conditions: Amyotrophic Lateral Sclerosis, ALS Functional Ration Scale | Phase 1, Phase 2 | Status: COMPLETED